Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma
Oncology Reports · 2026
DOI: 10.3892/or.2026.9196 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Oncology Reports, 2026. Verfasst von Daniel Zezulinski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Baruch S. Blumberg Institute, Doylestown, PA 18902, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baruch S. Blumberg Institute, Doylestown, PA 18902, USA.
- Division of Gastroenterology and Hepatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.
- Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Capital Health Cancer Center, Pennington, NJ 08534, USA.
Zitieren
APA
Zezulinski, D., Hoteit, M. A., Kaplan, D. E., Zhan, T., Doria, C., Block, T. M., & Sayeed, A. (2026). Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma. Oncology Reports. https://doi.org/10.3892/or.2026.9196
Vancouver
Zezulinski D, Hoteit MA, Kaplan DE, Zhan T, Doria C, Block TM, et al. Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma. Oncology Reports. 2026. doi:10.3892/or.2026.9196
BibTeX
@article{Zezulinski2026,
author = {Zezulinski, Daniel and Hoteit, Maarouf A and Kaplan, David E and Zhan, Tingting and Doria, Cataldo and Block, Timothy M and Sayeed, Aejaz},
title = {Validation of next‑generation sequencing‑derived circulating mRNA variants as potential diagnostic tools in hepatocellular carcinoma and cholangiocarcinoma},
journal = {Oncology Reports},
year = {2026},
doi = {10.3892/or.2026.9196}
}
EUVIMED